Ylä-Herttuala S - Search Results

1

Experimental Evaluation of an Interferometric Light Microscopy Particle Counter for Titering and Characterization of Virus Preparations.

Turkki V, Alppila E, Ylä-Herttuala S, Lesch HP. Turkki V, et al. Viruses. 2021 May 19;13(5):939. doi: 10.3390/v13050939. Viruses. 2021. PMID: 34069520 Free PMC article.

2

Optimized self-excising Cre-expression cassette for mammalian cells.

Mähönen AJ, Airenne KJ, Lind MM, Lesch HP, Ylä-Herttuala S. Mähönen AJ, et al. Biochem Biophys Res Commun. 2004 Jul 23;320(2):366-71. doi: 10.1016/j.bbrc.2004.05.175. Biochem Biophys Res Commun. 2004. PMID: 15219836

3

Generation of lentivirus vectors using recombinant baculoviruses.

Lesch HP, Turpeinen S, Niskanen EA, Mähönen AJ, Airenne KJ, Ylä-Herttuala S. Lesch HP, et al. Gene Ther. 2008 Sep;15(18):1280-6. doi: 10.1038/gt.2008.76. Epub 2008 May 8. Gene Ther. 2008. PMID: 18463689

4

Improving safety of gene therapy.

Räty JK, Lesch HP, Wirth T, Ylä-Herttuala S. Räty JK, et al. Curr Drug Saf. 2008 Jan;3(1):46-53. doi: 10.2174/157488608783333925. Curr Drug Saf. 2008. PMID: 18690980 Review.

5

A 96-well format for a high-throughput baculovirus generation, fast titering and recombinant protein production in insect and mammalian cells.

Kärkkäinen HR, Lesch HP, Määttä AI, Toivanen PI, Mähönen AJ, Roschier MM, Airenne KJ, Laitinen OH, Ylä-Herttuala S. Kärkkäinen HR, et al. BMC Res Notes. 2009 Apr 23;2:63. doi: 10.1186/1756-0500-2-63. BMC Res Notes. 2009. PMID: 19389242 Free PMC article.

6

Avidin fusion protein-expressing lentiviral vector for targeted drug delivery.

Lesch HP, Pikkarainen JT, Kaikkonen MU, Taavitsainen M, Samaranayake H, Lehtolainen-Dalkilic P, Vuorio T, Määttä AM, Wirth T, Airenne KJ, Ylä-Herttuala S. Lesch HP, et al. Hum Gene Ther. 2009 Aug;20(8):871-82. doi: 10.1089/hum.2009.007. Hum Gene Ther. 2009. PMID: 19419273

7

(Strept)avidin-displaying lentiviruses as versatile tools for targeting and dual imaging of gene delivery.

Kaikkonen MU, Lesch HP, Pikkarainen J, Räty JK, Vuorio T, Huhtala T, Taavitsainen M, Laitinen T, Tuunanen P, Gröhn O, Närvänen A, Airenne KJ, Ylä-Herttuala S. Kaikkonen MU, et al. Gene Ther. 2009 Jul;16(7):894-904. doi: 10.1038/gt.2009.47. Epub 2009 May 14. Gene Ther. 2009. PMID: 19440224

8

Production of HIV-1 integrase fusion protein-carrying lentiviral vectors for gene therapy and protein transduction.

Schenkwein D, Turkki V, Kärkkäinen HR, Airenne K, Ylä-Herttuala S. Schenkwein D, et al. Hum Gene Ther. 2010 May;21(5):589-602. doi: 10.1089/hum.2009.051. Hum Gene Ther. 2010. PMID: 20039782

9

Avidin-biotin technology in targeted therapy.

Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S. Lesch HP, et al. Expert Opin Drug Deliv. 2010 May;7(5):551-64. doi: 10.1517/17425241003677749. Expert Opin Drug Deliv. 2010. PMID: 20233034 Review.

10

Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors.

Lesch HP, Laitinen A, Peixoto C, Vicente T, Makkonen KE, Laitinen L, Pikkarainen JT, Samaranayake H, Alves PM, Carrondo MJ, Ylä-Herttuala S, Airenne KJ. Lesch HP, et al. Gene Ther. 2011 Jun;18(6):531-8. doi: 10.1038/gt.2010.162. Epub 2011 Jan 20. Gene Ther. 2011. PMID: 21248790

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

754 results

Search Page